RETA (GIP/GLP-1/GCG)

Overview

Retatrutide is a research peptide studied for its activity across three metabolic signaling pathways: glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. This triple-receptor activity has made it an important compound in research examining metabolic regulation, energy balance, and nutrient signaling.

We keep things straightforward: clean labeling, clarity-first specifications, and access to testing documentation so you can verify exactly what you’re working with.

Key research highlights (in plain terms)

Triple-receptor signaling — activates GIP, GLP-1, and glucagon receptors, allowing researchers to examine how these interconnected pathways influence metabolic signaling.

Glucose regulation — studied for its effects on pathways involved in insulin response, glucose handling, and pancreatic beta-cell function.

Energy balance — investigated in metabolic research examining energy intake, energy expenditure, and how the body regulates stored versus utilized energy.

Lipid metabolism — research explores how glucagon and incretin signaling may influence lipid utilization, circulating lipids, and broader metabolic processes.

Why Pegasus

Purity you can verify: third-party HPLC testing with documentation available

Clarity in every vial: straightforward specifications and labeling

Consistency you can trust: stable sourcing and careful handling

Specifications

Form: Lyophilized powder

Appearance: White to off-white

Purity: ≥98% (HPLC)

Solubility: Appropriate research-grade solvent or buffer as required by experimental protocol

Packaging: Individually labeled research vial

Storage & handling

Store lyophilized material at −20 °C, protected from light and moisture.

After reconstitution, aliquot as appropriate for the research protocol and store frozen to minimize repeated freeze–thaw cycles.